skip to main content

Chemistry, part 3

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > amino oligosaccharide > glucosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > amino oligosaccharide > glucosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > amino oligosaccharide > glucosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide derivative > amino oligosaccharide > glucosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide derivative > amino oligosaccharide > glucosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide derivative > amino oligosaccharide > glucosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > amino oligosaccharide > galactosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > amino oligosaccharide > galactosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > amino oligosaccharide > galactosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide derivative > amino oligosaccharide > galactosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide derivative > amino oligosaccharide > galactosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide derivative > amino oligosaccharide > galactosamine oligosaccharide > alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac

Preferred term

alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->6)]-d-galnac  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C56H92N4O41

has_role

inchi

  • InChI=1S/C56H92N4O41/c1-14-31(74)37(80)38(81)50(90-14)97-45-30(60-18(5)69)49(94-25(12-65)41(45)95-51-39(82)46(34(77)23(10-63)92-51)100-55(53(85)86)6-19(70)27(57-15(2)66)43(98-55)32(75)21(72)8-61)89-13-26-36(79)42(29(48(84)91-26)59-17(4)68)96-52-40(83)47(35(78)24(11-64)93-52)101-56(54(87)88)7-20(71)28(58-16(3)67)44(99-56)33(76)22(73)9-62/h14,19-52,61-65,70-84H,6-13H2,1-5H3,(H,57,66)(H,58,67)(H,59,68)(H,60,69)(H,85,86)(H,87,88)/t14-,19-,20-,21+,22+,23+,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34-,35-,36-,37+,38-,39+,40+,41+,42+,43+,44+,45+,46-,47-,48?,49+,50-,51-,52-,55-,56-/m0/s1

inchikey

  • UMVJMFYOZWEWPJ-CTOGLWHLSA-N

mass

  • 1477.33190

monoisotopicmass

  • 1476.52370

smiles

  • [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@@H](O)[C@@H](CO[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@]([H])(O5)[C@H](O)[C@H](O)CO)C(O)=O)[C@H]4O)[C@H](O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H]3NC(C)=O)OC(O)[C@@H]2NC(C)=O)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO

subset

  • 3_STAR

synonym EXACT

  • 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-D-galactopyranose

synonym RELATED

  • alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->6)]-D-GalpNAc
  • Neu5Aca2-3Galb1-4(Fuca1-3)GlcNAcb1-6(Neu5Aca2-3Galb1-3)GalNAc
  • Neu5Acalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Neu5Acalpha2-3Galbeta1-3)GalNAc
  • WURCS=2.0/5,7,6/[a2112h-1x_1-5_2*NCC/3=O][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O][a2122h-1b_1-5_2*NCC/3=O][a1221m-1a_1-5]/1-2-3-4-5-2-3/a3-b1_a6-d1_b3-c2_d3-e1_d4-f1_f3-g2

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:65192

Download this concept:

RDF/XML TURTLE JSON-LD